Eurofins Scientific SE ERFSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $84.81
- Day Range
- $82.04–86.12
- 52-Week Range
- $64.95–92.97
- Bid/Ask
- $55.80 / $121.39
- Shares Outstanding
- 171.11M
- Market Cap
- $14.42B
- Volume/Avg
- 335 / 1,869
Key Statistics
- Price/Earnings (Normalized)
- 19.35
- Price/Sales
- 1.76
- Dividend Yield (Trailing)
- 1.02%
- Dividend Yield (Forward)
- 1.02%
- Dividend Payment Schedule
- Apr
- Total Yield
- 3.32%
Company Profile
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. It is active in food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 65,000
- Website
- https://www.eurofins.com
Competitors
Valuation
|
Metric
|
ERFSF
|
BVI
|
SGSN
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.35 | 20.74 | 25.55 |
Price/Book Value | 3.47 | 7.19 | 18.44 |
Price/Sales | 1.76 | 1.84 | 2.55 |
Price/Cash Flow | 9.92 | 12.36 | 15.45 |
Price/Earnings
ERFSF
BVI
SGSN
Financial Strength
|
Metric
|
ERFSF
|
BVI
|
SGSN
|
|---|---|---|---|
Quick Ratio | 0.87 | 1.10 | 0.93 |
Current Ratio | 1.13 | 1.29 | 0.95 |
Interest Coverage | 5.15 | 8.19 | 11.63 |
Quick Ratio
ERFSF
BVI
SGSN
Profitability
|
Metric
|
ERFSF
|
BVI
|
SGSN
|
|---|---|---|---|
Return on Assets (Normalized) | 6.96% | 9.35% | 9.61% |
Return on Equity (Normalized) | 21.47% | 40.08% | 88.73% |
Return on Invested Capital (Normalized) | 9.71% | 15.36% | 13.55% |
Return on Assets
ERFSF
BVI
SGSN
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|^&SNrtW | LOCK|mKX | $241B | |||
| Danaher Corp
DHR
| LOCK|$y%dlGg | LOCK|Vbb | $149B | |||
| Agilent Technologies Inc
A
| LOCK|zF<w%!P | LOCK|w< | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|hm<wVl | LOCK|wP<<V | $43B | |||
| Waters Corp
WAT
| LOCK|xr$q#kv | LOCK|^x | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|lP>G^mW | LOCK|#r% | $41B | |||
| Illumina Inc
ILMN
| LOCK|K#!HZXX | LOCK|Ml<@! | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|>Cm#$<^ | LOCK|xs@N | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|^q^@ZKJ | LOCK|V?RR$ | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|!n%l^>Q | LOCK|B!QR@ | $25B |
United States